We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
+5.4%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$11.7B
AUM Growth
-$85.1M
(-0.72%)
Cap. Flow
-$913M
Cap. Flow
% of AUM
-7.78%
Top 10 Holdings %
Top 10 Hldgs %
14.67%
Holding
957
New
26
Increased
374
Reduced
426
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VEON
VEON
|
+$43.6M |
| 2 |
Brunswick
BC
|
+$22.9M |
| 3 |
Mondelez International
MDLZ
|
+$21.2M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$20.9M |
| 5 |
ASML
ASML
|
+$19.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$44.1M |
| 2 |
GGP
GGP Inc.
GGP
|
+$41.2M |
| 3 |
Apple
AAPL
|
+$34.2M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$30.1M |
| 5 |
Microsoft
MSFT
|
+$28.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.75% |
| 2 | Financials | 13.67% |
| 3 | Healthcare | 13.62% |
| 4 | Consumer Discretionary | 12.79% |
| 5 | Industrials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
26
DELISTED
Allergan plc
AGN
| $59.9M | 0.51% |
366,274
-34,801
| -9% | -$6.25M |
|
27
Chevron
CVX
$385B
| $59.9M | 0.51% |
478,516
-129,669
| -21% | -$15.4M |
|
28
Edwards Lifesciences
EW
$51.1B
| $59.7M | 0.51% |
1,588,164
-37,935
| -2% | -$1.39M |
|
29
Verizon
VZ
$197B
| $57.5M | 0.49% |
1,085,558
+48,292
| +5% | +$2.37M |
|
30
Northrop Grumman
NOC
$77.9B
| $57.3M | 0.49% |
186,838
-26,717
| -13% | -$8.02M |
|
31
Broadcom
AVGO
$1.87T
| $56.9M | 0.48% |
2,213,050
-661,680
| -23% | -$17.2M |
|
32
PepsiCo
PEP
$191B
| $56.3M | 0.48% |
470,711
-114,318
| -20% | -$13.1M |
|
|
33
VEON
VEON
$3.68B
| $55.6M | 0.47% |
579,663
+445,890
| +333% | +$43.6M |
|
34
British American Tobacco
BTI
$128B
| $55.2M | 0.47% |
823,409
-6,205
| -0.7% | -$405K |
|
35
Booking.com
BKNG
$149B
| $55.1M | 0.47% |
792,225
-65,175
| -8% | -$4.72M |
|
36
Walt Disney
DIS
$170B
| $51.9M | 0.44% |
482,552
-32,426
| -6% | -$3.34M |
|
37
Sabre
SABR
$779M
| $50.7M | 0.43% |
2,472,532
+194,376
| +9% | +$3.72M |
|
38
Starbucks
SBUX
$118B
| $50.6M | 0.43% |
881,640
+99,938
| +13% | +$5.66M |
|
39
Hasbro
HAS
$12.9B
| $48.6M | 0.41% |
534,988
+73,727
| +16% | +$6.92M |
|
40
Mastercard
MA
$500B
| $48.2M | 0.41% |
318,506
-55,920
| -15% | -$8.32M |
|
41
HDFC Bank
HDB
$124B
| $47.5M | 0.41% |
1,870,400
-538,224
| -22% | -$12.9M |
|
|
BERY
42
DELISTED
Berry Global Group, Inc.
BERY
| $47.2M | 0.4% |
876,885
-116,820
| -12% | -$6.36M |
|
43
Constellation Brands
STZ
$22.4B
| $46.8M | 0.4% |
204,619
+1,422
| +0.7% | +$307K |
|
|
44
Mondelez International
MDLZ
$78.8B
| $46.7M | 0.4% |
1,091,790
+503,987
| +86% | +$21.2M |
|
45
Kimco Realty
KIM
$17.1B
| $46M | 0.39% |
2,534,490
+718,413
| +40% | +$13.4M |
|
46
Medtronic
MDT
$111B
| $45.5M | 0.39% |
562,922
+155,252
| +38% | +$12.4M |
|
47
Danaher
DHR
$139B
| $45.2M | 0.39% |
549,576
+55,203
| +11% | +$4.49M |
|
48
Abbott
ABT
$185B
| $44.9M | 0.38% |
786,054
-147,175
| -16% | -$8.16M |
|
|
49
Bristol-Myers Squibb
BMY
$134B
| $44.1M | 0.38% |
719,498
-481,727
| -40% | -$30.1M |
|
50
Boston Scientific
BSX
$70.2B
| $44M | 0.37% |
1,773,977
-388,809
| -18% | -$10.7M |
|
Similar funds
BNP Paribas Asset Management's Q4 2017 Portfolio in Review
As of Q4 2017, BNP Paribas Asset Management held 957 positions worth $11.7B, down 0.72% from $11.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Asset Management withdrew a net $913M in Q4 2017, closing 41 positions and reducing 426 holdings. Its most notable exit was MACOM Technology Solutions, an estimated $11.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Asset Management opened a new position in CyrusOne Inc Common Stock worth $20.6M.
- BNP Paribas Asset Management's largest Q4 2017 buy was CyrusOne Inc Common Stock: 345,330 shares worth $20.6M.
- BNP Paribas Asset Management added most to VEON in Q4 2017, an estimated $43.6M increase.
- BNP Paribas Asset Management's biggest Q4 2017 reduction was Charles Schwab, cutting an estimated $44.1M.
- BNP Paribas Asset Management fully exited MACOM Technology Solutions in Q4 2017, selling an estimated $11.7M.
- BNP Paribas Asset Management's ten largest holdings make up 15% of its $11.7B portfolio in Q4 2017.
- BNP Paribas Asset Management opened 26 new positions and closed 41 in Q4 2017.
- BNP Paribas Asset Management's portfolio value fell 0.72% quarter-over-quarter to $11.7B.
Based on BNP Paribas Asset Management's 13F filing for Q4 2017, filed 1 Feb 2018.